Statement of Principles concerning radiation burn (Reasonable Hypothesis) (No. 5 of 2024)

The instrument establishes a small set of legal‑medical concepts that will determine whether a claimant has raised the statutory threshold of a “reasonable hypothesis” connecting radiation burn to service. The central concepts and their statutory anchors are:

• Radiation burn, as a defined medical entity, limited to skin and external body covering tissues resulting from external exposure to ionising radiation (s 7(2)(a)). The instrument expressly includes ionising radiation burns of deep tissues and organs only where they form part of a multiple burn injury that includes skin/external tissue injury (s 7(2)(b)). Explicit exclusions are ultraviolet radiation burns and isolated internal organ ionising radiation burns (s 7(2)(c)(i)-(ii)).

• Clinical onset and temporality. The first factor requires exposure sufficient to cause at least erythema at the affected area within 30 days before the clinical onset of radiation burn (s 9(1)). The 30‑day window is therefore a temporal limitation that links a particular exposure event to the clinical manifestations.

• Medical management and access. The second factor is inability to obtain appropriate clinical management for radiation burn prior to clinical worsening (s 9(2)). The instrument uses the phrase “inability to obtain appropriate clinical management”, which is the operative concept for service‑related contribution or aggravation where healthcare access during service is implicated.

• Relationship to relevant service. Any factor relied upon under section 9 must be related to the person’s relevant service, where relevant service is defined exhaustively in the Schedule to include operational service, peacekeeping, hazardous service, British nuclear test defence service under the VEA, and warlike or non‑warlike service under the MRCA (Schedule 1). The second factor has a further temporal limitation: it only operates to establish material contribution or aggravation where the radiation burn was suffered or contracted before or during, but did not arise out of, relevant service (s 10(2)).

• Death as a connected outcome. The instrument treats “radiation burn” in relation to a person as including death from a terminal event or condition contributed to by the radiation burn. The Schedule defines “terminal event” with examples such as pneumonia, respiratory failure, cardiac arrest, circulatory failure, and cessation of brain function (s 7(3); Schedule 1).

• Cross‑SoP interaction. If a factor in section 9 refers to an injury or disease covered by another SoP, then the factors in that other SoP apply as in force from time to time (s 11). This creates a mechanism for overlapping medical conditions to be dealt with using the other instrument’s criteria.

The Repatriation Medical Authority states it is of the view that there is sound medical‑scientific evidence linking radiation burn and death from radiation burn to relevant service (s 8). That statement is an explanatory basis for the SoP; the operative effect is the listing of the factors and the definitional boundaries described above.

This instrument affects three primary populations and several decision points in the VEA/MRCA claims process.

Claimants: The SoP applies to veterans and members whose claims fall under section 120A of the VEA or section 338 of the MRCA (s 5). The Schedule’s definition of relevant service clarifies the cohorts whose service can engage the instrument: operational service under the VEA; peacekeeping; hazardous service; British nuclear test defence service under the VEA; and warlike or non‑warlike service under the MRCA (Schedule 1). Thus persons who seek to establish that radiation burn, or death from radiation burn, is connected to the listed types of service must meet the criteria in section 9 and the relationship test in section 10.

Decision makers and medical assessors: The Repatriation Medical Authority itself determines the SoP (s 3), but the SoP functions as a medical framework for claim decision makers under the VEA and MRCA. Those decision makers will use the listed factors to decide whether a reasonable hypothesis has been raised. The instrument therefore affects the evidentiary standard used by claims assessors, medical officers, and lawyers preparing claims.

Clinical providers and record keepers: The first factor’s reliance on a finding of erythema within 30 days of clinical onset (s 9(1)) and the second factor’s reliance on inability to obtain appropriate clinical management (s 9(2)) place evidentiary weight on contemporaneous clinical records, service medical logs, and treatment‑access documentation. Clinicians and health record custodians will be relied upon to provide the medical evidence that supports or disproves the stated factors.

Related SoP authors and administrators: Because section 11 provides that factors in other SoPs apply where cross‑references exist, authors and administrators of other SoPs are affected insofar as their instruments may be invoked by reference. The repeal in section 4 of the external burn No. 110 of 2015 transfers any claims previously assessed under that instrument to the new radiation burn SoP from commencement (s 4).

Wider stakeholders (administrative and legal advisers): Lawyers, advocates, and representatives preparing claims must address the specific limited factors here. The SoP narrows the medical linkages that can be advanced to establish a reasonable hypothesis, so advisers must structure evidentiary bundles to satisfy the particular temporal, clinical, and service‑relationship tests in sections 9 and 10.

The instrument does not itself create entitlements or payments; rather it prescribes the medical criteria used to assess whether a condition can be connected to relevant service. That linkage governs eligibility under the VEA/MRCA processes to obtain benefits administered under those Acts. The instrument therefore affects who will need to compile service records, medical records, radiation exposure records, and treatment access evidence to meet the stated factors.

This instrument does not create freestanding administrative duties or rights of payment. Instead it prescribes medical criteria for the statutory test of whether a reasonable hypothesis has been raised linking radiation burn or death from radiation burn to relevant service. Key operative duties and rights flow from that role within the claims process.

Duty to apply the SoP in claims assessment: Decision makers assessing claims under section 120A of the VEA or section 338 of the MRCA must consider whether the factors listed in section 9 exist and are related to relevant service per section 10. The SoP therefore imposes an evidentiary duty on assessing bodies to consider these specific factors when determining whether a reasonable hypothesis exists.

Duty to relate factors to relevant service: Section 10(1) requires that any factor from section 9 relied upon must be related to the person’s relevant service. The duty to establish this connection falls on the claimant who seeks to satisfy the reasonable hypothesis threshold, and on the decision maker to evaluate whether the evidentiary materials satisfy the requirement.

Duty to consider cross‑referenced SoPs: If a factor in section 9 refers to an injury or disease covered by another SoP then, under section 11, the decision maker must apply the factors contained in that other SoP as in force from time to time. This creates a duty to consult and apply additional SoP material where cross‑reference triggers.

Right to have death included where contributory: Section 7(3) extends the definition of “radiation burn” to include death from a terminal event or condition that was contributed to by the person’s radiation burn. The Schedule defines terminal events. Claimants therefore have the right to have death considered as part of a radiation burn claim if they establish contribution.

Right to have treatment‑access matters considered: The second factor (s 9(2)) gives claimants who can show inability to obtain appropriate clinical management prior to clinical worsening an evidentiary route to establishing a reasonable hypothesis. This creates a procedural right to have restricted access to care considered as a potential material contribution or aggravation factor, subject to the temporal limitation in section 10(2).

No new administrative obligations on service providers stated: The instrument does not impose explicit duties on the Department, health providers, or the Services to provide records, treatment, or to act in a particular fashion. The practical consequence is that decision makers will rely on existing records and evidence to apply the SoP; the instrument itself does not mandate record creation or retention practices.

No standalone right to compensation: The SoP is a determinative instrument for one element of the statutory test. Whether a successful link ultimately gives rise to payment or other entitlements is governed by the VEA and MRCA provisions and administrative practices that are not restated in the SoP. In short, the SoP defines medical criteria; rights to benefits remain contingent on satisfying all statutory and administrative requirements outside this instrument.

The instrument itself does not create criminal offences, civil penalties, or an enforcement regime. It is a medical‑scientific instrument designed to inform the statutory process for determining whether a reasonable hypothesis exists under the VEA and MRCA. There are therefore no penalty provisions, infringement notices, or administrative fines within the text.

Enforcement in practice occurs through claim decision making: The practical effect of the SoP is to constrain or guide administrative decisions about entitlement to repatriation or rehabilitation benefits under the VEA and MRCA. The instrument will be enforced by adjudicators and medical assessors when they determine whether the claimant has satisfied the reasonable hypothesis threshold. Any consequences,acceptance or rejection of a claim,are administrative outcomes under the VEA or MRCA legal framework; remedies, reviews, appeals, and any penalties for false statements or fraud would be those available under the relevant Acts and administrative law, not this instrument.

No express evidentiary presumption or burden‑shifting: The SoP sets factors that “must as a minimum exist before it can be said that a reasonable hypothesis has been raised” (s 9). It does not itself prescribe the evidentiary standard beyond that phrase, nor does it create legal presumptions that impose penalties for non‑compliance. The phrase operates as the medical threshold for reasonable hypothesis; how decision makers treat that threshold in evidentiary terms is governed by the VEA/MRCA decision framework.

Potential for administrative dispute: Because the SoP establishes narrow criteria, disagreements about factual findings,such as whether exposure was “sufficient to cause at least erythema” within 30 days (s 9(1)), or whether a person was unable to obtain appropriate clinical management before clinical worsening (s 9(2)),are likely to be the locus of dispute. Remedies for adverse administrative decisions will be those provided by the VEA and MRCA appeals and review mechanisms. The instrument itself does not prescribe sanctions against medical practitioners, record keepers, or agencies for the presence or absence of evidence.

No stated review or amendment mechanism within the instrument: The SoP does not include internal enforcement clauses for periodic review or mandatory updates. The Repatriation Medical Authority retains the power to determine SoPs under the VEA, and any changes would be made by separate instrument under the same statutory mechanism.

This instrument operates within the statutory architecture of the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. Its legal effect is to state the medical factors relevant to the determination of whether a reasonable hypothesis exists that radiation burn, or death from radiation burn, is connected with relevant service. Interaction with other laws is limited to the duties and procedures that arise under those Acts.

Statutory source and application: The instrument is made under subsection 196B(2) of the VEA (s 3). It applies to claims to which section 120A of the VEA or section 338 of the MRCA applies (s 5). Therefore the SoP functions as an evidentiary and medical standard within those statutory schemes. The instrument itself does not amend the substantive entitlement provisions of either Act; it supplies the medical criteria applied under those Acts.

Repeal of prior SoP: The instrument expressly repeals the Statement of Principles concerning external burn No. 110 of 2015 (s 4). That repeal operates by removing the earlier SoP from the body of SoPs used to assess claims. Consequently any provision or factor previously applied under the external burn SoP is replaced by the new radiation burn SoP from the commencement date. For claims spanning the repeal, decision makers will need to apply the current SoP in force for the particular claim as per statutory interpretation principles that govern the application of SoPs in claims administration.

Cross‑SoP referencing: Section 11 provides an explicit interaction rule with other SoPs. If a factor in section 9 refers to an injury or disease already covered by another SoP, then the factors in that other SoP apply in accordance with that SoP as in force from time to time. This creates a legal interaction whereby the network of SoPs can be combined if the medical issues intersect. Decision makers must therefore consult the full set of SoPs when factors invoke other conditions.

Scope limitations vis‑à‑vis other medical or statutory regimes: The instrument excludes ultraviolet radiation burns and isolated ionising radiation burns of internal organs (s 7(2)(c)). Where a claimant advances an excluded condition, the SoP does not apply; the claimant must rely on other legal frameworks or SoPs to the extent available. The instrument also confines its operation to claims in the VEA/MRCA domain; it does not create obligations under general occupational health, workers’ compensation, public health, or criminal law statutes.

Interpretative duties under VEA/MRCA: Because the SoP supplies criteria for raising a reasonable hypothesis, it interacts with the legal standards for burden of proof, evidentiary thresholds, and review available under the VEA and MRCA. The instrument does not restate those legal standards, but it will be applied within the administrative and judicial processes established by the Acts and any external review bodies empowered to hear disputes arising under them.

No express conflict‑resolution hierarchy: The instrument does not provide an internal rule about how conflicts between SoPs are to be resolved beyond section 11. Where multiple SoPs might be relevant to a claim, adjudicators will need to determine which SoP(s) supply the operative factors. Section 11 instructs use of other SoPs where a section 9 factor refers to an injury or disease covered by another SoP.

The instrument itself records a limited amendment history in two respects visible within the text.

New instrument and commencement: The document is identified as Statement of Principles concerning radiation burn (Reasonable Hypothesis) (No. 5 of 2024) and is dated 22 December 2023 (cover) with a commencement date of 22 January 2024 (s 2). That gives a single identified amending action: the adoption of this replacement SoP and the commencement date for its legal operation.

Repeal of previous SoP: Section 4 expressly repeals the Statement of Principles concerning external burn No. 110 of 2015 (Federal Register of Legislation No. F2015L01330) which had been made under subsections 196B(2) and (8) of the VEA. That repeal indicates that the SoP framework for burns previously addressed by the 2015 instrument is replaced as of the commencement date. The instrument does not list any other historical amendments, prior versions, or transitional provisions beyond this repeal.

No transitional or saving provisions in the text: The instrument does not include transitional rules specifying how claims that straddle the repeal date are to be treated, nor does it state whether claims lodged prior to commencement remain governed by the prior SoP. Practitioners must therefore infer that the repeal removes the earlier instrument and the new SoP applies from the commencement date in the statutory environment, with any further transitional handling governed by the VEA/MRCA adjudicative practice or separate administrative guidance.

No stated sunset, review clause, or periodic amendment schedule: The instrument contains no clause requiring periodic review, monitoring, or automatic amendment. Any future change will therefore require a fresh instrument made under the relevant statutory power.

Record of authority: The instrument records that it is made under subsection 196B(2) of the VEA (s 3) and bears the seal and signature of the Repatriation Medical Authority chairperson on the dated instrument. That provides the statutory provenance for the introduced change, but the text does not detail any internal RMA deliberations or evidence base beyond the statement in section 8 that the Authority is of the view there is sound medical‑scientific evidence indicating a relationship between radiation burn and relevant service.

In short, the textual amendment history in the instrument is limited to its creation and commencement date and the affirmative repeal of the 2015 external burn SoP. Any further amendment history will be recorded in later instruments or amendments made under the same statutory power.

The instrument does not record any litigation history. No cases, judicial decisions, or tribunal determinations are cited within the text. The Schedule, sections, and repeal provision contain only the substantive medical criteria, definitions, and the Repatriation Medical Authority’s statement of basis (s 8). Consequently there is no recorded judicial interpretation, appeal outcome, or statutory challenge referenced in the instrument.

That absence, read against the content of the SoP, suggests a predictable locus for future disputes that could generate litigation or administrative review. The instrument introduces specific phrases and thresholds that are likely to be focal points in contested decisions: for example, the meaning and application of “exposure to ionising radiation sufficient to cause at least erythema” within 30 days before clinical onset (s 9(1)); the meaning of “inability to obtain appropriate clinical management” and how to prove it (s 9(2)); the temporal and causal nexus required by section 10; and the interpretation of the exclusion of isolated internal organ ionising radiation burns (s 7(2)(c)(ii)).

Disputes may centre on evidentiary sufficiency. The SoP requires that “at least one” of the factors in section 9 must exist for a reasonable hypothesis to be raised. Administrative reviewers or courts may be asked to scrutinise whether medical records, dosimetry, service logs, witness statements, or other materials meet those factors. The instrument’s cross‑reference mechanism in section 11 adds complexity where factors refer to conditions covered by other SoPs, and litigation might arise over which SoP applies or how conflicts between SoPs are resolved.

Because the instrument treats death as included where a terminal event was contributed to by radiation burn (s 7(3)), disputes may arise about causation at death, proximate versus contributory causes, and the evidentiary threshold for contribution to terminal events listed in the Schedule. The Schedule gives examples of terminal events such as pneumonia and respiratory failure, which are clinically common end‑points; litigated issues could therefore involve expert medical evidence about whether radiation burn materially contributed to those outcomes.

Finally, the repeal of the 2015 external burn SoP (s 4) opens potential transitional disputes for claims commenced before but decided after the repeal date. Absent transitional provisions in the instrument, litigants may challenge which instrument governs particular claims or assert retrospective expectations. The instrument does not itself provide litigation history or guidance on these matters; any legal precedents will be developed in administrative reviews and judicial decisions after the instrument’s commencement.

The instrument contains several tightly worded features that can cause practical surprises for claimants, medical assessors, and advisers if they are not read carefully.

Narrow injury definition and exclusions. Radiation burn is narrowly defined as injury to skin and external body covering tissues from external exposure to ionising radiation (s 7(2)(a)). Isolated ionising radiation injury to internal organs, such as respiratory, gastrointestinal, or internal genitourinary tracts, are expressly excluded (s 7(2)(c)(ii)). Ultraviolet radiation burns are also excluded (s 7(2)(c)(i)). Practically, this means that claims grounded in internal organ radiation injury or sunburn/UV exposure will not be assessed under this SoP; claimants must look to other SoPs or legal bases.

Timing constraint for exposure. The first listed factor requires exposure sufficient to cause at least erythema at the affected area within 30 days before clinical onset (s 9(1)). The 30‑day window is an exact temporal test. If exposure predates 30 days before clinical onset or erythema develops outside that window, the first factor will not be satisfied. Practitioners must ensure that clinical notes, onset dates, and any dosimetry or exposure records are tightly aligned to prove the 30‑day linkage.

Erythema threshold. The instrument requires exposure “sufficient to cause at least erythema” (s 9(1)). The phrase “at least erythema” sets a clinical minimum that may be contested. Disputes can arise over whether documented skin changes qualify as erythema and whether those changes were caused by the referenced exposure. Expect need for dermatological/expert evidence.

Access to treatment is narrowly framed. The second factor allows the inability to obtain appropriate clinical management to be the basis for a reasonable hypothesis (s 9(2)). However, section 10(2) restricts the operation of this factor to situations where the radiation burn was suffered or contracted before or during, but did not arise out of, relevant service. That means the second factor is not a free‑standing route in all service settings; it is limited to cases where service materially contributed to worsened outcomes through lack of access to care.

Relationship to relevant service must be demonstrated. Section 10(1) requires that any factor in section 9 be related to the person’s relevant service. The Schedule defines relevant service narrowly and exhaustively (Schedule 1). Failure to establish a nexus between the exposure or lack of treatment and the listed service types will defeat reliance on the SoP.

Death requires contribution, not sole cause. The SoP treats death as included where a terminal event or condition was “contributed to” by the person’s radiation burn (s 7(3)). Contribution is different to sole causation. The Schedule lists terminal events such as pneumonia and cardiac arrest. Because these are relatively common proximate causes of death, a claimant must adduce evidence that the radiation burn materially contributed to those terminal events.

Cross‑SoP referral. Section 11 requires application of another SoP where a section 9 factor refers to an injury or disease covered by that other SoP. Practitioners must search the SoP corpus to identify whether any factor implicates another SoP; failure to do so may omit material criteria.

No transitional text for repeal. Section 4 repeals the earlier external burn SoP, but the instrument contains no transitional provisions. Claims that bridge the repeal date may be sensitive to which instrument is applied. Practitioners should check administrative guidance and claim timelines.

Absence of procedural particulars. The SoP sets medical criteria but does not specify how to demonstrate them evidentially. For example, it does not define what documentation proves “inability to obtain appropriate clinical management” or how to quantify exposure sufficient to cause erythema. Claimants must therefore assemble robust contemporaneous records, expert opinion, and where available, dosimetry or incident reports.

Potential semantic ambiguity. Phrases such as “clinical onset”, “clinical worsening”, “appropriate clinical management”, and “suffered or contracted” are open to clinical interpretation. These terms will require supporting medical evidence and may be the subject of administrative or judicial interpretation.

Taken together, these technical limitations mean that claim preparation must align precise medical facts, exact timing, and clear service relationship evidence to the explicit wording of sections 7, 9, 10, and Schedule 1.

To apply the SoP effectively in a claim context, parties should compile documentation and structure arguments that directly correspond to the instrument’s specified factors and definitions. The following practical steps map to the operative sections and Schedule.

1. Confirm application and relevant service. Verify the claim falls under section 120A of the VEA or section 338 of the MRCA (s 5), and identify which category of relevant service (Schedule 1) is engaged: operational, peacekeeping, hazardous, British nuclear test defence service, warlike, or non‑warlike service. Provide service records showing dates, locations, and circumstances to establish the connection to relevant service required by section 10(1).

2. Establish the injury type and exclusions. Ensure the condition is a skin/external body covering injury caused by external exposure to ionising radiation as defined in section 7(2)(a). If the injury is isolated to internal organs or is ultraviolet in origin, the SoP does not apply (s 7(2)(c)); pursue alternative SoPs or legal bases. Where there is a multiple burn injury including deep tissues, document the skin involvement so the inclusion in s 7(2)(b) is satisfied.

3. Satisfy section 9(1) timing and clinical criteria. If relying on the exposure factor, produce contemporaneous clinical records that show:

   • the date(s) of the ionising radiation exposure event(s);
   • objective clinical findings of erythema at the affected area(s);
   • the clinical onset date of the radiation burn; and
   • that erythema occurred within the 30‑day window before clinical onset (s 9(1)). Where possible, include photographs, clinical notes, dermatology reports, and dosimetry or incident reports that quantify exposure.

4. Satisfy section 9(2) access to care factor. If relying on inability to obtain appropriate clinical management, assemble evidence demonstrating that:

   • there was a recognised need for appropriate clinical management prior to clinical worsening;
   • the claimant could not obtain that management (for example, service medical logs showing lack of availability, administrative denial, absence of evacuation, or documented delays); and
   • those deficiencies preceded the clinical worsening. Remember the additional temporal constraint in section 10(2): this factor applies only where the radiation burn was suffered or contracted before or during, but did not arise out of, the person’s relevant service.

5. Demonstrate relationship to service. For whichever factor is relied upon, link the exposure or inability to obtain management to the claimant’s relevant service. This requires contemporaneous service documentation, incident reports, witness statements from service personnel, or unit logs that connect the exposure or the lack of care to the service event.

6. Where death is involved, establish contribution. If a death is claimed to be from radiation burn, provide medical records, death certificates, and expert opinion showing that the radiation burn contributed to the terminal event listed in the Schedule. The Schedule gives examples of terminal events; show how the burn materially contributed to the proximate or ultimate cause of death (s 7(3); Schedule 1).

7. Check cross‑SoP references. Where any factor refers to another injury or disease covered by another SoP, identify and apply the factors in that SoP as required by section 11. Incorporate the additional medical criteria into the evidence bundle and obtain experts who can speak to both instruments if necessary.

8. Use appropriate expert evidence. Given the clinical thresholds and interpretive terms in the instrument, obtain specialist medical opinions addressing:

   • whether exposure was sufficient to cause erythema;
   • the timing of exposure relative to onset;
   • whether the clinical presentation is consistent with ionising radiation burn as defined; and
   • whether the absence of treatment materially contributed to worsening or death. Experts should comment specifically on the statutory phrases used in the SoP.

9. Preserve and present contemporaneous records. Because the SoP relies on timing and clinical findings, contemporaneous notes, photographs, incident reports, service medical logs, treatment requests, and denials are crucial. Where dosimetry is available, include that data.

10. Anticipate exclusions and prepare alternatives. If a claimant’s condition partially overlaps an exclusion (for example, internal organ involvement without skin injury), prepare alternative legal bases or other SoPs that might apply. Section 11 requires consideration of other SoPs only when section 9 factors refer to those injuries; do not assume automatic overlap.

11. Document chain of causation for aggravation claims. If service aggravated a pre‑existing radiation burn by denying access to treatment, assemble pre‑service medical records showing the pre‑existing condition, then service records showing the aggravating event or lack of management, and then post‑service clinical deterioration.

12. Prepare for administrative review and potential challenges. Given that the SoP sets narrow criteria, be prepared to address contested factual findings about erythema, exposure intensity, causation, and access to care. That preparation should include robust expert reports pointedly linked to the statutory wording.

Following these steps aligns the evidence collection and claim presentation directly to the SoP’s operative language in sections 7, 9, 10, 11, and the Schedule. The SoP is technical and narrow; compliance requires evidentiary precision rather than broad clinical argument.